Crossmark

Acyclic retinoid and angiotensin-II receptor blocker exert a combined protective effect against diethylnitrosamine-induced hepatocarcinogenesis in diabetic OLETF rats

Crossref DOI link: https://doi.org/10.1186/s12885-018-5099-6

Published Online: 2018-11-26

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nishimura, Norihisa

Kaji, Kosuke

Kitade, Mitsuteru

Aihara, Yosuke

Sato, Shinya

Seki, Kenichiro

Sawada, Yasuhiko

Takaya, Hiroaki

Okura, Yasushi

Kawaratani, Hideto

Moriya, Kei

Namisaki, Tadashi

Mitoro, Akira

Yoshiji, Hitoshi
Funding

Funding for this research was provided by:

Japan Society for Promotion of Science (17 K09438)
License Information

Text and Data Mining valid from 2018-11-26

Version of Record valid from 2018-11-26
More Information

Article History

Received: 20 October 2018

Accepted: 15 November 2018

First Online: 26 November 2018

Ethics approval and consent to participate

: All the animal procedures were performed as per the recommendations of the Guide for Care and Use of Laboratory Animals (National Research Council). The study was approved by the animal facility committee of Nara Medical University (permit No. 10842).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below